BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 11425777)

  • 1. Glimepiride, a novel sulfonylurea, does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide.
    Mocanu MM; Maddock HL; Baxter GF; Lawrence CL; Standen NB; Yellon DM
    Circulation; 2001 Jun; 103(25):3111-6. PubMed ID: 11425777
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning?
    Hausenloy DJ; Maddock HL; Baxter GF; Yellon DM
    Cardiovasc Res; 2002 Aug; 55(3):534-43. PubMed ID: 12160950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral glyburide, but not glimepiride, blocks the infarct-size limiting effects of pioglitazone.
    Ye Y; Lin Y; Perez-Polo JR; Birnbaum Y
    Cardiovasc Drugs Ther; 2008 Dec; 22(6):429-36. PubMed ID: 18825491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Opening of mitochondrial K(ATP) channels triggers the preconditioned state by generating free radicals.
    Pain T; Yang XM; Critz SD; Yue Y; Nakano A; Liu GS; Heusch G; Cohen MV; Downey JM
    Circ Res; 2000 Sep; 87(6):460-6. PubMed ID: 10988237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of mitochondrial and sarcolemmal K(ATP) channels in ischemic preconditioning of the canine heart.
    Sanada S; Kitakaze M; Asanuma H; Harada K; Ogita H; Node K; Takashima S; Sakata Y; Asakura M; Shinozaki Y; Mori H; Kuzuya T; Hori M
    Am J Physiol Heart Circ Physiol; 2001 Jan; 280(1):H256-63. PubMed ID: 11123240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of diabetic state and that of different sulfonylureas on the size of myocardial infarction with and without ischemic preconditioning in rabbits.
    Nieszner E; Posa I; Kocsis E; Pogátsa G; Préda I; Koltai MZ
    Exp Clin Endocrinol Diabetes; 2002 Aug; 110(5):212-8. PubMed ID: 12148084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Second-generation sulfonylureas preserve inhibition of mitochondrial permeability transition by the mitochondrial K+(ATP) opener nicorandil in experimental myocardial infarction.
    Argaud L; Garrier O; Loufouat J; Gomez L; Couture-Lepetit E; Gateau-Roesch O; Robert D; Ovize M
    Shock; 2009 Sep; 32(3):247-52. PubMed ID: 19174741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual roles of mitochondrial K(ATP) channels in diazoxide-mediated protection in isolated rabbit hearts.
    Wang S; Cone J; Liu Y
    Am J Physiol Heart Circ Physiol; 2001 Jan; 280(1):H246-55. PubMed ID: 11123239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of glibenclamide, glimepiride, and gliclazide on ischemic preconditioning in rat heart.
    Wu GT; Wang L; Li J; Zhu WZ
    Chin Med Sci J; 2007 Sep; 22(3):162-8. PubMed ID: 17966164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral hypoglycemic sulfonylurea glimepiride preserves the myoprotective effects of ischemic preconditioning.
    Horimoto H; Nakai Y; Mieno S; Nomura Y; Nakahara K; Sasaki S
    J Surg Res; 2002 Jun; 105(2):181-8. PubMed ID: 12121705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of ATP-sensitive potassium channel blockers in ischemia-reperfusion-induced renal injury versus their effects on cardiac ischemia reperfusion in rats.
    Tawfik MK; Abo-Elmatty DM; Ahmed AA
    Eur Rev Med Pharmacol Sci; 2009; 13(2):81-93. PubMed ID: 19499842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opening of mitochondrial ATP-sensitive potassium channels enhances cardioplegic protection.
    Toyoda Y; Levitsky S; McCully JD
    Ann Thorac Surg; 2001 Apr; 71(4):1281-8; discussion 1288-9. PubMed ID: 11308175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adenosine and a nitric oxide donor enhances cardioprotection by preconditioning with isoflurane through mitochondrial adenosine triphosphate-sensitive K+ channel-dependent and -independent mechanisms.
    Wakeno-Takahashi M; Otani H; Nakao S; Uchiyama Y; Imamura H; Shingu K
    Anesthesiology; 2004 Mar; 100(3):515-24. PubMed ID: 15108963
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ischemic preconditioning with opening of mitochondrial adenosine triphosphate-sensitive potassium channels or Na/H exchange inhibition: which is the best protective strategy for heart transplants?
    Kevelaitis E; Oubénaissa A; Mouas C; Peynet J; Menasché P
    J Thorac Cardiovasc Surg; 2001 Jan; 121(1):155-62. PubMed ID: 11135172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of mitochondrial ATP-sensitive K(+) channel for cardiac protection against ischemic injury is dependent on protein kinase C activity.
    Wang Y; Hirai K; Ashraf M
    Circ Res; 1999 Oct; 85(8):731-41. PubMed ID: 10521247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Both metabolic inhibition and mitochondrial K(ATP) channel opening are myoprotective and initiate a compensatory sarcolemmal outward membrane current.
    Irie H; Gao J; Gaudette GR; Cohen IS; Mathias RT; Saltman AE; Krukenkamp IB
    Circulation; 2003 Sep; 108 Suppl 1():II341-7. PubMed ID: 12970257
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardioprotective effects of sodium ferulate mediated by nitric oxide on ischemia-reperfusion injured myocardium: experiment with isolated rat hearts].
    Liu JC; Kang J; Shao LJ; He M
    Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):987-91. PubMed ID: 16759542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection.
    Hausenloy D; Wynne A; Duchen M; Yellon D
    Circulation; 2004 Apr; 109(14):1714-7. PubMed ID: 15066952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of pressure overload on cardioprotection of mitochondrial KATP channels and GSK-3beta: interaction with the MPT pore.
    Mozaffari MS; Schaffer SW
    Am J Hypertens; 2008 May; 21(5):570-5. PubMed ID: 18437149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MCC-134, a single pharmacophore, opens surface ATP-sensitive potassium channels, blocks mitochondrial ATP-sensitive potassium channels, and suppresses preconditioning.
    Sasaki N; Murata M; Guo Y; Jo SH; Ohler A; Akao M; O'Rourke B; Xiao RP; Bolli R; Marbán E
    Circulation; 2003 Mar; 107(8):1183-8. PubMed ID: 12615799
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.